You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 7, 2025

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
Published on: March 29, 2024
Sara Castagnola1, Julie Cazareth1, Kevin Lebrigand1
1Université Côte d'Azur, CNRS, Institute of Molecular Cellular Pharmacology, F-06560 Valbonne, France.
Researchers created a new method called aiFACS that sorts individual cells based on how they react to specific chemical signals in real-time. By combining this sorting with genetic profiling, they mapped how different brain cells function. Using this approach on mouse models, they identified specific defects in brain cell responses linked to fragile X syndrome.
Area of Science:
Background:
Current methods often fail to capture the immediate, individual responses of cells to external stimuli within complex tissues. This limitation prevents a complete understanding of how cellular environments influence dynamic behavior. Prior research has shown that bulk analysis obscures the heterogeneity present in biological samples. That uncertainty drove the need for techniques capable of real-time monitoring at the single-cell level. No prior work had resolved how to link functional reactivity directly to genetic expression profiles. This gap motivated the development of tools that isolate cells based on their unique physiological signatures. Scientists have long sought to bridge the divide between pharmacological responsiveness and transcriptomic identity. Such integration remains a significant hurdle for mapping tissue function in both healthy and diseased states.
Purpose Of The Study:
The aim of this study is to introduce a novel technique for the simultaneous recording and sorting of cells based on their immediate functional responses. This method addresses the challenge of capturing dynamic interactions between individual cells and their environment. The researchers seek to overcome limitations in existing approaches that fail to link physiological reactivity with genetic identity. By developing this tool, they intend to enable the construction of functional tissue maps for any normal or pathological sample. The motivation stems from the need to better characterize cellular heterogeneity in complex tissues like the brain. The authors propose that modulating selection parameters allows for versatile analysis across different developmental stages and stimuli. They aim to demonstrate the utility of this platform by applying it to a mouse model of fragile X syndrome. This work provides a framework for investigating how specific pharmacological responses correlate with transcriptomic profiles in health and disease.
Main Methods:
The researchers developed a technique for simultaneous recording and sorting of cells based on individual responses to stimuli. This design relies on modulating selection parameters to analyze diverse normal or pathological tissue samples. The team tested various developmental time points and multiple readouts to ensure comprehensive data collection. They applied this approach to dissociated mouse brain tissue to isolate specific interneuron populations. Stimulation with KCl or AMPA triggered measurable changes in intracellular calcium levels for real-time sorting. Following isolation, the investigators performed genetic profiling on the selected cells to identify distinct subtypes. This workflow allowed for the construction of a functional tissue map based on pharmacological reactivity. The study also compared interneurons from wild-type mice with those derived from a rodent model of fragile X syndrome.
Main Results:
The strongest finding demonstrates that interneurons from the Fmr1-KO mouse exhibit a generalized defective response to AMPA stimulation. This functional impairment impacts all nine identified cell clusters at a specific postnatal developmental stage. The researchers successfully classified the aiFACS-selected interneurons into nine distinct clusters using single-cell transcriptomics. By applying the sorting technique to dissociated mouse brain, the team achieved significant enrichment of interneuron populations. The data show that these cells display unique calcium signaling profiles when exposed to glutamate receptor agonists. Comparisons between mutant and wild-type cells reveal clear differences in their immediate physiological reactivity. These results confirm that the sorting platform can effectively distinguish cell subtypes based on their functional behavior. The study provides a proof of concept for mapping tissue heterogeneity through the integration of pharmacological and genetic data.
Conclusions:
The authors propose that their novel sorting platform enables the creation of detailed functional tissue maps. This approach successfully links specific pharmacological reactions to distinct genetic expression patterns in heterogeneous samples. The researchers suggest that their method provides a robust framework for identifying cellular abnormalities in pathological conditions. Their findings indicate that fragile X syndrome models exhibit widespread functional impairments across various interneuron subtypes. This evidence supports the view that developmental timing influences the severity of these observed physiological deficits. The team concludes that their technique offers a versatile tool for investigating diverse tissue types beyond the central nervous system. These results highlight the potential for using functional sorting to characterize disease-specific cellular phenotypes. Future applications may leverage this strategy to better understand the interplay between environmental stimuli and cell-type-specific responses.
The researchers propose that aiFACS sorts cells by monitoring real-time calcium fluctuations following exposure to stimuli like KCl or AMPA. This mechanism allows for the simultaneous isolation of individual cells based on their immediate physiological reactivity to pharmacological agents.
The authors utilize single-cell transcriptomics to generate high-resolution genetic profiles of the sorted interneurons. This data type provides the necessary molecular information to construct a functional cartography of the tissue based on the observed pharmacological responses.
The team explains that the mouse brain is a highly heterogeneous tissue, necessitating a method that can distinguish between diverse cell types. Using KCl or AMPA as triggers is required to selectively enrich interneurons based on their unique calcium signaling profiles.
The researchers employ the Fmr1-KO mouse as a model for fragile X syndrome. They compare these mutant cells against wild-type controls to identify generalized defects in their response to AMPA stimulation at specific developmental stages.
The study measures the calcium levels of individual cells as a proxy for their immediate functional state. This measurement allows the researchers to sort cells into distinct groups based on their sensitivity to the applied pharmacological stimulus.
The authors claim that their approach reveals a generalized defective response to AMPA in interneurons from the fragile X model. They propose this impairment affects all identified cell clusters at a defined postnatal time point.